Lonvi Biosciences, a Shenzen-based startup specializing in longevity and bioscience, recently announced that it has formulated a pill that targets ‘zombie cells’ – aging cells that no longer divide but continue to trigger inflammation – and can theoretically help people live for as long as 150 years.
“This is not just another pill. This is the Holy Grail,” Lonvi Chief Executive Officer Ip Zhu, said, adding that the main ingredient of this new miracle drug is capable of not just increasing longevity, but also reducing age-related diseases by strengthening health at the cellular level.